Evogene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evogene Limited with three other
miscellaneous service companies in Middle East:
sales of 1.70 million Israel Shekels [US$487,262.36 ]
Redhill Biopharma Ltd
(386,233.09 Israel Shekels [US$110,509.01 ]
Clal Biotechnology Industries Limited
(25.01 million Israel Shekels [US$7.15 million]
of which 68%
Evogene Limited reported sales of 25.01 million Israel Shekels (US$7.16 million)
December of 2016.
decrease of 42.2%
versus 2015, when the company's sales were 43.25 million Israel Shekels.